ELS Group has been named a finalist for the 2025 Sindusfarma Quality Award in two key categories: Quality Control Consulting and Storage & Distribution of Medicines. This achievement highlights the company as one of the few consultancies recognized in multiple categories, reinforcing its position as a leading provider of specialized services for the Brazilian pharmaceutical industry.
Dr. Diogo Sousa-Martins, Founder and President of ELS Group, stated:
“Being a finalist in two categories of such a prestigious award as the Sindusfarma Quality Award is a significant recognition of the work ELS Group has been doing for the healthcare industry in Brazil. We are deeply grateful for the trust our clients have placed in us—our most valuable asset.”
Key Highlights of the Nomination
-
In Quality Control Consulting, ELS Group stands out for its technical-regulatory expertise and strict adherence to ANVISA regulations.
-
In Storage & Distribution, the company has been recognized for developing innovative logistics solutions that ensure the integrity of medicines throughout the supply chain.
The awards ceremony will take place on June 9, 2025, when the winners in each category will be announced. This dual nomination further solidifies ELS Group’s reputation for quality and innovation in the Brazilian pharmaceutical sector.
About Sindusfarma
The Sindicato da Indústria de Produtos Farmacêuticos (Sindusfarma) is Brazil’s leading pharmaceutical industry association, representing national and international companies that account for over 95% of the country’s pharmaceutical market. The industry generates approximately 100,000 direct jobs and over 600,000 indirect jobs.
Want to Learn More About ELS Group’s Services?
Contact one of our local consultants or email us at info@elssolutions.pt.
